Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Intellectual outcome from preschool traumatic brain injury: a 5-year prospective, longitudinal study

Anderson V, Catroppa C, Morse S, Haritou F, Rosenfeld JV

(2009), Pediatrics, 124(6), e1064-71

Early intervention for mild cognitive impairment: a randomised controlled trial

Kinsella GJ, Mullaly E, Rand E, Ong B, Burton C, Price S, Phillips M, Storey E

(2009), J Neurol Neurosurg Psychiatry, 80(7), 730-6

Isolated unilateral ptosis and mydriasis from ventral midbrain infarction

Chen L, Maclaurin W, Gerraty RP

(2009), J Neurol, 256(7), 1164-5

Predicting the effectiveness of virtual reality relaxation on pain and anxiety when added to PCA morphine in patients having burns dressings changes

Konstantatos AH, Angliss M, Costello V, Cleland H, Stafrace S

(2009), Burns, 35(4), 491-9

Iatrogenic chemical burns associated with tourniquet use and prep solution

Hubik DJ, Connors A, Cleland H

(2009), ANZ J Surg, 79(10), 762

Methodological quality of randomised controlled trials in burns care. A systematic review

Danilla S, Wasiak J, Searle S, Arriagada C, Pedreros C, Cleland H, Spinks A

(2009), Burns, 35(7), 956-61

Are we ready for the next big thing?

Cleland HJ

(2009), Med J Aust, 191(7), 412-3

End-of-life decision making – where have all the surgeons gone?

Cleland H, Mahar P

(2009), ANZ J Surg, 79(12), 865-6

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

Watson AJ, Middleton MR, McGown G, Thorncroft M, Ranson M, Hersey P, McArthur G, Davis ID, Thomson D, Beith J, Haydon A, Kefford R, Lorigan P, Mortimer P, Sabharwal A, Hayward O, Margison GP

(2009), Br J Cancer, 100(8), 1250-6

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

Thürlimann B, Price KN, Gelber RD, Holmberg SB, Crivellari D, Colleoni M, Collins J, Forbes JF, Castiglione-Gertsch M, Coates AS, Goldhirsch A

(2009), Breast Cancer Res Treat, 113(1), 137-44

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group

Gianni L, Gelber S, Ravaioli A, Price KN, Panzini I, Fantini M, Castiglione-Gertsch M, Pagani O, Simoncini E, Gelber RD, Coates AS, Goldhirsch A

(2009), Eur J Cancer , 45(4), 561–71

Patients' views on decision making in advanced cancer

Philip J, Gold M, Schwarz M, Komesaroff P

(2009), Palliat Support Care, 7(2), 181-5

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93

Pagani O, Gelber S, Simoncini E, Castiglione-Gertsch M, Price KN, Gelber RD, Holmberg SB, Crivellari D, Collins J, Lindtner J, Thürlimann B, Fey MF, Murray E,Forbes JF, Coates AS, Goldhirsch A; International Breast Cancer Study Group

(2009), Breast Cancer Res Treat, 116(3), 491-500

What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?

Olver IN, Haines IE

(2009), Med J Aust, 190(2), 74-7

The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer

Lijovic M, Davis SR, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Bell RJ

(2009), Fam Cancer, 8(4), 299-305

An Australian clinical perspective: management of hormone refractory (androgen-independent) prostate cancer

Hovey E, Marx G, Kneebone A, Patel M, Shapiro J

(2009), Asia-Pacific J Oncol Hematol, 1(1), 82-3

Are guidelines on use of colony-stimulating factors in solid cancers flawed?

Haines IE, Olver I

(2009), Intern Med J, 39(4), 259-62

A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

Haines I, Elliott P, Stanley R

(2009), Intern Med J, 39(4), 269-71

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group; BIG 1-98 Collaborative Group

(2009), Clin Trials, 6(3), 272-87

Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer

Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR

(2009), J Womens Health, 18(12), 1975-80

676 677 678 679 680